By continuing to browse the site you are agreeing to our use of cookies and similar tracking technologies described in our privacy policy.

Search

Resource Library

Home
Test, Evaluate, Monitor
Treatment-Naive
Treatment-Experienced Patients
Unique & Key Populations
About

Resource Library

Sofosbuvir and velpatasvir for HCV genotype 1, 2, 4, 5, and 6 infection

Journal

N Engl J Med

Year of Publication

2015

Volume

373

Issue

27

Pagination

2599-2607

Authors

Jordan Feld
Ira Jacobson
Christophe Hézode
Tarik Asselah
Peter Ruane
Norbert Gruener
Armand Abergel
Alessandra Mangia
Ching-Lung Lai
Henry Chan
Francesco Mazzotta
Christophe Moreno
Eric Yoshida
Stephen Shafran
William Towner
Tram Tran
John McNally
Anu Osinusi
E. Svarovskaia
Yanni Zhu
Diana Brainard
John McHutchison
Kosh Agarwal
Stefan Zeuzem
ASTRAL-1 Investigators

Keywords

Adult Aged Aged, 80 and over Antiviral Agents Carbamates Double-Blind Method Drug Combinations Drug Resistance, Viral Female Genotype Hepacivirus Hepatitis C, Chronic Heterocyclic Compounds, 4 or More Rings Humans Liver Cirrhosis Male Middle Aged Recurrence sofosbuvir Treatment Outcome Viral Nonstructural Proteins

Type of Article

Journal Article

Test, Evaluate, Monitor
Treatment-Naive
Treatment-Experienced Patients
Unique & Key Populations

Resource Library
About Us
Announcements
Contact Us

Terms of Use
Privacy Policy
Cookies Policy
Accessibility

© 2025 HCV Guidelines All right reserved.

Website by Yoko Co